2-Year GLOBE trial results Telbivudine is superior to lamivudine in patients with chronic hepatitis B

查看全文 作　　者：Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV; GLOBE Study Group 出　　处：《Gastroenterology》索引2009年第136卷第2期,共0页